Sarepta Therapeutics Inc (NASDAQ:SRPT) stock has had a difficult year gaining traction.
Year-to-date, SRPT stock is down 36%, but that’s not the whole story. At 9:30 a.m. on April 26, SRPT stock was registering a loss of 79% year-to-date. That is a painful loss to digest and this investment can best be described as a weapon of wealth destruction. The cause of all this volatility stems from negative news that has been surrounding a breakthrough drug Sarepta is seeking Food & Drug Administration (FDA) approval.
The following news-driven events caused the share price volatility:
It is incredible to imagine, but we can expect minimum moves of 20% in share price based on any news surrounding the drug. Who can sleep at night knowing they can wake up the next morning to such volatility? SRPT stock is not for the faint of heart.
Perhaps the chart below can shed some light and help investors gain a foothold. The SRPT stock chart below contains year-to-date data.
The post Sarepta Therapeutics Inc: This Chart Shows Where SRPT Stock Could Go Next appeared first on Profit Confidential.